glp 1 intracranial hypertension Effect of glucagon like peptide-1 receptor agonist exenatide, used as an pressure lowering agent, on cognition in Idiopathic Intracranial Management of IIH. The treatment

Research-Grade vs Pharma-Grade Peptide Companies: What Is the Difference

A survey that included more than 8,000 GLP-1 users found that 15% had tried or were currently microdosing the drug

These findings suggest that while GLP-1 medications produce generalized fat loss throughout the body, abdominal fat deposits appear to respond as part of this overall weight reduction, likely due to the metabolically active nature of visceral adipose tissue

Lets debunk the myths about this natural bodily compound, which has been garnering attention lately

For a broader explanation of how research peptides function in scientific studies, read our Ultimate Guide to Research Peptides

Meet our experts: Kerri Louati , MS, RD, LDN, CDE, director of women's health clinical operations at LifeMD